药明康德

- 603259

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
药明康德(603259) 利润表
单位:万元
报表日期2023-06-302023-03-312022-12-312022-09-302022-06-30
一、营业总收入1,887,128.55896,374.163,935,477.782,839,456.181,775,625.80
营业收入1,887,128.55896,374.163,935,477.782,839,456.181,775,625.80
二、营业总成本1,315,519.22677,522.862,980,081.072,115,992.161,344,242.89
营业成本1,122,547.78538,788.152,467,721.681,785,375.581,131,930.91
营业税金及附加11,690.086,028.0920,047.449,070.654,091.76
销售费用35,347.4117,585.3873,158.6655,529.9635,561.40
管理费用127,285.2164,904.27282,554.75204,002.68126,964.48
财务费用-48,055.7714,486.87-24,796.81-46,913.52-20,025.64
研发费用66,704.5035,730.10161,395.34108,926.8265,719.99
资产减值损失----------
公允价值变动收益31,099.2116,460.8577,007.86109,520.2090,726.66
投资收益32,022.2717,755.9318,794.9042,098.3123,297.90
其中:对联营企业和合营企业的投资收益-6,877.89-3,750.05-4,627.11-10,725.72-6,940.05
汇兑收益----------
三、营业利润641,244.05261,535.481,065,224.85884,219.63555,437.21
加:营业外收入494.04381.44964.50623.95469.79
减:营业外支出2,216.801,029.654,341.712,916.611,820.86
其中:非流动资产处置损失----------
四、利润总额639,521.29260,887.281,061,847.65881,926.98554,086.14
减:所得税费用103,831.6742,306.81171,586.59137,265.2186,520.27
五、净利润535,689.62218,580.46890,261.05744,661.76467,565.87
归属于母公司所有者的净利润531,311.97216,812.84881,371.30737,791.39463,574.93
少数股东损益4,377.651,767.638,889.756,870.373,990.94
六、每股收益
基本每股收益(元/股)1.81000.74003.01002.52001.5900
稀释每股收益(元/股)1.79000.72002.82002.30001.4800
七、其他综合收益-51,366.85-1,791.5829,310.80-75,205.18-29,858.79
八、综合收益总额484,322.77216,788.88919,571.86669,456.58437,707.08
归属于母公司所有者的综合收益总额480,696.65214,960.14910,913.80663,778.91434,245.90
归属于少数股东的综合收益总额3,626.121,828.748,658.065,677.683,461.18
下载全部历史数据到excel中 返回页顶